TARDBP and proteostasis deficiencies: Taken together, high-affinity antibodies targeting the RRM2 or the C-terminal low complexity domain potently suppress TDP-43 phase separation, aggregation, and cellular aggregate uptake, all processes implicated in TDP-43 proteinopathies.